ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes by Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND). by Aung, T, Haynes, R, Barton, J, Cox, J, Murawska, A, Murphy, K, Lay, M, Armitage, J, Bowman, L, ASCEND Study Collaborative Group

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial by Emily L. Sammons, Georgina Buck, Louise J. Bowman, William M. Stevens, Imen Hammami, Sarah Parish, Jane Armitage, on behalf of the ASCEND Study Collaborative Group

Get full text

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial by Sarah Parish, Georgina Buck, Theingi Aung, Marion Mafham, Sarah Clark, Michael R. Hill, Rory Collins, Louise Bowman, Jane Armitage, on behalf of the ASCEND Study Collaborative Group

Get full text

Effects of aspirin for primary prevention in persons with diabetes mellitus by Bowman, L, Mafham, M, Wallendszus, K, Stevens, W, Buck, G, Barton, J, Murphy, K, Haynes, R, Jolyon, R, Murawska, A, Young, A, Lay, M, Chen, F, Sammons, E, Waters, E, Simpson, D, Peto, R, Baigent, C, Collins, R, Parish, S, Armitage, J, Farmer, A, Neil, A, Ascend Study Collaborative Group

Effects of n-3 fatty acid supplements in diabetes mellitus by Ascend Study Collaborative Group, Bowman, L, Mafham, M, Wallendszus, K, Stevens, W, Buck, G, Barton, J, Murphy, K, Aung, T, Haynes, R, Cox, J, Murawska, A, Young, A, Lay, M, Chen, F, Sammons, E, Waters, E, Adler, A, Bodansky, J, Farmer, A, McPherson, R, Neil, A, Simpson, D, Peto, R, Baigent, C, Collins, R, Parish, S, Armitage, J

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial by Parish, S, Mafham, M, Offer, A, Barton, J, Wallendszus, K, Stevens, W, Buck, G, Haynes, R, Collins, R, Bowman, L, Armitage, J

Other Authors: “…ASCEND Study Collaborative Group…”

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial by Rocca, B, Buck, G, Petrucci, G, Parish, S, Pagliaccia, F, Baigent, C, Mafham, M, Bowman, L, Armitage, J, Patrono, C

Other Authors: “…The ASCEND Study Collaborative Group…”

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial by Parish, S, Buck, G, Aung, T, Mafham, M, Clark, S, Hill, M, Collins, R, Bowman, L, Armitage, J

Other Authors: “…ASCEND Study Collaborative Group…”

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial by Petrucci, G, Buck, GA, Rocca, B, Parish, S, Baigent, C, Hatem, D, Mafham, M, Habib, A, Bowman, L, Armitage, J, Patrono, C

Other Authors: “…ASCEND Study Collaborative Group…”

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy by Sammons, E, Buck, G, Bowman, L, Armitage, J, Parish, S, Hammami, I, Stevens, W

Other Authors: “…ASCEND Study Collaborative Group…”

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial by Sammons, EL, Buck, G, Bowman, LJ, Stevens, WM, Hammami, I, Parish, S, Armitage, J

Other Authors: “…ASCEND Study Collaborative Group…”

ASCEND-Eye: effects of aspirin on diabetic retinopathy by Sammons, E, Buck, G, Bowman, L, Stevens, W, Hammami, I, Parish, S, Armitage, J

Other Authors: “…ASCEND Study Collaborative Group…”

Decrements in health‐related quality of life associated with adverse events in people with diabetes by Keng, MJ, Leal, J, Bowman, L, Armitage, J, Mihaylova, B

Other Authors: “…The ASCEND Study Collaborative Group…”